Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Annelise, Segers"'
Autor:
Thomas Vanassche, Rachel P. Rosovsky, Fares Moustafa, Harry R. Bu¨ller, Annelise Segers, Indu Patel, Minggao Shi, Naoki Miyoshi, Venkatesh Mani, Zahi Fayad, Dominique Stephan, Jeannot Schmidt, Michael A. Grosso, Victor F. Tapson, Peter Verhamme, Menno V. Huisman
Publikováno v:
Journal of Thrombosis and Haemostasis.
Autor:
Marjolein P. A. Brekelmans, Harry R. Büller, Michele F. Mercuri, Walter Ageno, Cathy Z. Chen, Alexander T. Cohen, Nick van Es, Michael A. Grosso, Andria P. Medina, Gary Raskob, Annelise Segers, Thomas Vanassche, Peter Verhamme, Philip S. Wells, George Zhang, Jeffrey I. Weitz
Publikováno v:
TH Open, Vol 02, Iss 01, Pp e1-e7 (2018)
Pulmonary embolism (PE) studies used direct oral anticoagulants (DOACs) with or without initial heparin. We aimed to (1) evaluate if PE patients benefit from initial heparin; (2) describe patient characteristics in the DOAC studies; and (3) investiga
Externí odkaz:
https://doaj.org/article/834b7b370e214a23b27ecd10f0a037ed
Autor:
H. R. Büller, Annelise Segers, Michele Mercuri, Peter Verhamme, Anil Duggal, Noémie Kraaijpoel, J. I. Weitz, Manila Gaddh, Sudeep Shivakumar, N. van Es, Michael A. Grosso, Marc Carrier, Tzu-Fei Wang, Gordon Royle, M. Di Nisio, Ajay K. Kakkar, George Zhang, Frits I. Mulder, David A. Garcia, Saskia Middeldorp, Gary E. Raskob
Publikováno v:
Thrombosis research, 185, 13-19. Elsevier Limited
Background The safety and efficacy of edoxaban and dalteparin is unclear for several cancer groups. Methods We evaluated the occurrence of the primary outcome in large cancer groups. The primary outcome was the composite of recurrent VTE or major ble
Autor:
Fisseha Tesfaye, Michael R. Lassen, John Strony, Renée M Swaim, Jeffrey I. Weitz, Gary Peters, Gary E. Raskob, Lee Michael, Peter M DiBattiste, Charles W. Francis, Annelise Segers, Takeshi Fuji, Robin S. Roberts
Publikováno v:
Journal of Thrombosis and Haemostasis
BACKGROUND JNJ-9375 is an antibody against exosite 1 on thrombin, inhibits substrate binding but not catalytic activity. OBJECTIVE To examine the possibility that JNJ-9375 attenuates thrombosis without affecting hemostasis, we compared the efficacy a
Autor:
Annelise Segers, Harry R. Büller, Marcello Di Nisio, Tzu-Fei Wang, Jeffrey I. Weitz, Nick van Es, David A. Garcia, Gary E. Raskob, Marc Carrier
Publikováno v:
Journal of thrombosis and haemostasis, 17(11), 1866-1874. Wiley-Blackwell
Background Patients with active cancer and venous thromboembolism (VTE) are at high risk of recurrence. Therefore, continued anticoagulant therapy beyond the initial 6 months is suggested in this patient population, but evidence supporting this appro
Autor:
Gary E. Raskob, Annelise Segers, Menno V. Huisman, Peter Verhamme, Saskia Middeldorp, Tzu-Fei Wang, Pieter Willem Kamphuisen, Floris T. M. Bosch, Jeffrey I. Zwicker, Nick van Es, David A. Garcia, Anil Duggal, Jeffrey I. Weitz, Harry R. Büller, Michael A. Grosso, Frits I. Mulder, Marc Carrier, Marcello Di Nisio
Publikováno v:
Journal of thrombosis and haemostasis, 19(12), 3008-3017. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 19, 12, pp. 3008-3017
Journal of Thrombosis and Haemostasis, 19(12), 3008-3017. WILEY
Journal of Thrombosis and Haemostasis, 19, 3008-3017
Journal of Thrombosis and Haemostasis, 19, 12, pp. 3008-3017
Journal of Thrombosis and Haemostasis, 19(12), 3008-3017. WILEY
Journal of Thrombosis and Haemostasis, 19, 3008-3017
BACKGROUND: In the Hokusai VTE Cancer study, the risk of major bleeding was 2.9% higher in the edoxaban group compared with the dalteparin group, mainly due to more gastrointestinal bleedings in patients with gastrointestinal cancer. The identificati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ffadf52633ecf6ab6a8890f22669072
https://pure.amc.nl/en/publications/risk-factors-for-gastrointestinal-bleeding-in-patients-with-gastrointestinal-cancer-using-edoxaban(a4d44fb1-a407-4335-8fd8-c7529fc98867).html
https://pure.amc.nl/en/publications/risk-factors-for-gastrointestinal-bleeding-in-patients-with-gastrointestinal-cancer-using-edoxaban(a4d44fb1-a407-4335-8fd8-c7529fc98867).html
Autor:
Jeffrey I. Weitz, Kenneth W. Mahaffey, Annelise Segers, Walter Ageno, Robin Roberts, John Strony, Elaine M. Hylek, Michael R. Lassen, David Gailani, Ravi S Notani, Gary E. Raskob, Axiomatic-Tkr Investigators
Publikováno v:
N Engl J Med
BACKGROUND: Factor XIa inhibitors for the prevention and treatment of venous and arterial thromboembolism may be more effective and result in less bleeding than conventional anticoagulants. Additional data are needed regarding the efficacy and safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94db605dba8c04157988c9a6f61c61ee
https://europepmc.org/articles/PMC9540352/
https://europepmc.org/articles/PMC9540352/
Autor:
Peter, Verhamme, B Alexander, Yi, Annelise, Segers, Janeen, Salter, Daniel, Bloomfield, Harry R, Büller, Gary E, Raskob, Jeffrey I, Weitz, Chernivtsi Y, Vasylchyshyn
Publikováno v:
New England journal of medicine, 385(7), 609-617. Massachussetts Medical Society
The role of factor XI in the pathogenesis of postoperative venous thromboembolism is uncertain. Abelacimab is a monoclonal antibody that binds to factor XI and locks it in the zymogen (inactive precursor) conformation.In this open-label, parallel-gro
Autor:
Marc Carrier, H. R. Büller, Floris T. M. Bosch, Frits I. Mulder, Michael A. Grosso, M. Di Nisio, David A. Garcia, Peter Verhamme, Jeffrey I. Weitz, Tzu-Fei Wang, Jean M. Connors, Annelise Segers, N. van Es, Gary E. Raskob
Publikováno v:
Thrombosis Research. 200:S14-S15
Autor:
Annelise Segers, Noémie Kraaijpoel, Marc Philip Righini, Grégoire Le Gal, Sam Schulman, Philippe Girard, Harry R. Büller, Nicole Langlois, Tobias Tritschler
Publikováno v:
Journal of thrombosis and haemostasis, 18(6), 1415-1420. Wiley-Blackwell
Tritschler, Tobias; Kraaijpoel, Noémie; Langlois, Nicole; Girard, Philippe; Schulman, Sam; Büller, Harry R; Segers, Annelise; Righini, Marc; Le Gal, Grégoire (2020). Development of a standardized definition of pulmonary embolism-related death: a cross-sectional survey of international thrombosis experts. Journal of thrombosis and haemostasis, 18(6), pp. 1415-1420. Wiley-Blackwell 10.1111/jth.14775
Journal of Thrombosis and Haemostasis, Vol. 18, No 6 (2020) pp. 1415-1420
Tritschler, Tobias; Kraaijpoel, Noémie; Langlois, Nicole; Girard, Philippe; Schulman, Sam; Büller, Harry R; Segers, Annelise; Righini, Marc; Le Gal, Grégoire (2020). Development of a standardized definition of pulmonary embolism-related death: a cross-sectional survey of international thrombosis experts. Journal of thrombosis and haemostasis, 18(6), pp. 1415-1420. Wiley-Blackwell 10.1111/jth.14775
Journal of Thrombosis and Haemostasis, Vol. 18, No 6 (2020) pp. 1415-1420
INTRODUCTION Pulmonary embolism (PE)-related death is often part of the primary outcome in venous thromboembolism (VTE) studies. The Scientific and Standardization Committee (SSC) of the International Society on Thrombosis and Haemostasis developed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a78ca3c6c4544c04e62f95e4c046ca
https://pure.amc.nl/en/publications/development-of-a-standardized-definition-of-pulmonary-embolismrelated-death-a-crosssectional-survey-of-international-thrombosis-experts(1ac80527-ef9a-4939-b4a9-696837a10c85).html
https://pure.amc.nl/en/publications/development-of-a-standardized-definition-of-pulmonary-embolismrelated-death-a-crosssectional-survey-of-international-thrombosis-experts(1ac80527-ef9a-4939-b4a9-696837a10c85).html